DiaMedica Therapeutics Inc. (DMAC)
NASDAQ · Healthcare
DiaMedica Therapeutics Inc. Operating Income 2018–2018
DiaMedica Therapeutics Inc. annual/quarterly operating income history and growth rate from 2018 to 2018. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- DiaMedica Therapeutics Inc. operating income for the quarter ending September 30, 2018 was -1.5 M.
- DiaMedica Therapeutics Inc. annual operating income for 2018 was -6.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
DiaMedica Therapeutics Inc. Operating Income — FAQ
DiaMedica Therapeutics Inc. (DMAC) operating income over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is DiaMedica Therapeutics Inc.'s operating income?
DiaMedica Therapeutics Inc. (DMAC) reported operating income of -$7M for fiscal 2018.
Where can I see DMAC's operating income history?
The chart and table above show DiaMedica Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.